JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesis

Lynch, JR; Salik, B; Connerty, P; Vick, B; Leung, H; Pijning, A; Jeremias, I; Spiekermann, K; Trahair, T; Liu, T; Haber, M; Norris, MD; Woo, AJ; Hogg, P; Wang, JL; Wang, JY

Wang, JY (reprint author), Univ New South Wales, Childrens Canc Inst, Canc & Stem Cell Biol Grp, Sydney, NSW 2052, Australia.

LEUKEMIA, 2019; 33 (6): 1400

Abstract

Abnormal metabolism is a fundamental hallmark of cancer and represents a therapeutic opportunity, yet its regulation by oncogenes remains poorly under......

Full Text Link